PolyPid Ltd. financial data

Symbol
PYPD on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
18 Hasivim Street, Petach Tikva, Israel
State of incorporation
Israel
Fiscal year end
December 31
Latest financial report
Q4 2023 - Mar 6, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.65M shares -91.7%
Common Stock, Shares, Outstanding 1.65M shares +147%
Weighted Average Number of Shares Outstanding, Basic 1.4M shares +117%
Weighted Average Number of Shares Outstanding, Diluted 1.42M shares +119%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 16.1M USD -42.3%
General and Administrative Expense 5.52M USD -31%
Operating Income (Loss) -22.9M USD +41.2%
Nonoperating Income (Expense) -929K USD -72%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -23.8M USD +39.6%
Income Tax Expense (Benefit) 69K USD -46.5%
Net Income (Loss) Attributable to Parent -23.9M USD +39.7%
Earnings Per Share, Basic 17 USD/shares -72.2%
Earnings Per Share, Diluted 16.9 USD/shares -72.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.31M USD -37.9%
Cash, Cash Equivalents, and Short-term Investments 15.1M USD -36.5%
Assets, Current 6.07M USD -57.3%
Property, Plant and Equipment, Net 7.62M USD -17.6%
Operating Lease, Right-of-Use Asset 1.6M USD -34.3%
Other Assets, Noncurrent 87K USD -12.1%
Assets 15.4M USD -40.8%
Employee-related Liabilities, Current 958K USD -17.9%
Accrued Liabilities, Current 995K USD -20.1%
Liabilities, Current 7.29M USD -14.8%
Long-term Debt and Lease Obligation 6.38M USD -15.8%
Operating Lease, Liability, Noncurrent 857K USD -26.9%
Other Liabilities, Noncurrent 18K USD +12.5%
Retained Earnings (Accumulated Deficit) -238M USD -11.1%
Stockholders' Equity Attributable to Parent -2.1M USD -136%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 28.8M USD -56.4%
Liabilities and Equity 15.4M USD -40.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.2M USD +49.8%
Net Cash Provided by (Used in) Financing Activities 9.98M USD -39.3%
Net Cash Provided by (Used in) Investing Activities 3.8M USD -77.1%
Common Stock, Shares Authorized 108M shares +126%
Common Stock, Shares, Issued 1.65M shares +147%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.69M USD -37.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.04M USD +41.4%
Deferred Tax Assets, Valuation Allowance 44.3M USD +9.62%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.23 pure 0%
Deferred Tax Assets, Gross 44.7M USD +8.95%
Operating Lease, Liability 1.4M USD -60.4%
Depreciation 1.82M USD +5.87%
Payments to Acquire Property, Plant, and Equipment 196K USD -88.9%
Lessee, Operating Lease, Liability, to be Paid 1.56M USD
Property, Plant and Equipment, Gross 15.4M USD +1.29%
Operating Lease, Liability, Current 540K USD -43.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 414K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 587K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure -20.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 162K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 374K USD
Deferred Tax Assets, Operating Loss Carryforwards 40.1M USD +14.7%
Current Income Tax Expense (Benefit) 129K USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 184K USD
Operating Lease, Payments 1.02M USD
Additional Paid in Capital 236M USD +7.24%
Operating Leases, Future Minimum Payments, Due in Two Years 358K USD
Operating Leases, Future Minimum Payments Due, Next Twelve Months 403K USD
Deferred Tax Assets, Net of Valuation Allowance 338K USD -39.5%
Share-based Payment Arrangement, Expense 3.39M USD -21.3%
Operating Leases, Future Minimum Payments, Due in Three Years 349K USD
Operating Leases, Future Minimum Payments Due 1.57M USD